Resilience-h2020

Resilience-h2020
Resilience-h2020
Developer: Centro Nacional Investigaciones
Category: Health & Fitness
Add App to Comparison
64 installs
Ratings not yet available
4.00 monthly active users
Revenue not available
Install Trends
Monthly +2.00
Steady

Resilience-h2020 Summary

Resilience-h2020 is a mobile Android app in Health And Fitness by Centro Nacional Investigaciones Cardiovasculares. Released in Jul 2023 (2 years ago). It has about 64+ installs Based on AppGoblin estimates, it reaches roughly 4.00 monthly active users . Store metadata: updated Jan 16, 2026.

Store info: Last updated on Google Play on Jan 16, 2026 .

SDKs, Trackers & Permissions

App not yet scanned for SDKs.

App Details
Store ID: es.cnic.resilienceh2020
First Released: 2023-07-18
Store Last Updated: 2026-01-16
In-App Purchases: No
Ads: No
Website: cnic.es
App Store
Crawl Status: Success
AppGoblin First Crawled: 2025-04-04
AppGoblin Last Crawled: 2026-03-16
Ads & App-Ads.txt
App does not have ads.
AppGoblin SDK Scans
App not yet analyzed for SDKs.

The download and scan process is automated but can require manual troubleshooting. Feel free to reach out if your request does not complete in 24hrs or if you have any questions.


0★

Ratings: 0

5★
4★
3★
2★
1★

Screenshots

App screenshot
App screenshot
App screenshot
App screenshot

App Description

Project Resilience - Cardiac prevention in cancer survivors

RESILIENCE Proyect

A European Commission-funded project aimed at reducing the incidence of heart failure in cancer survivors

Cancer survivors are at high risk for cardiovascular complications. Anthracyclines are an extremely effective treatment against many cancer types, but they can induce cardiac toxicity resulting in chronic heart failure.

RESILIENCE Project tests a novel preventive intervention (remote ischemic conditioning) in patients at risk for anthracycline-induced cardiotoxicity. In addition, new diagnostic modalities will be used to identify anthracyclines-induced cardiotoxicity in its very early stages.

RESILIENCE counts on a multidisciplinary consortium with the active participation of patients.